Company Data
Passage Bio Inc.
Ticker
PASG
Current Price
$4.43
Market Cap
$14.3M
Price Target
Refer to Report
Volume
56
52wk Range
$3.29 - $20
Overview
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.